Citius Pharmaceuticals In...
(CTXR)
undefined
undefined%
At close: undefined
4.30
-1.60%
Pre-market Jan 08, 2025, 05:32 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 194.32K | 179.68K | 164.87K | 152.36K | 893.00 | 1.75K | 2.63K | 1.34K | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | n/a | -194.32K | -179.68K | -164.87K | -152.36K | -893 | -1.75K | -2.63K | -1.34K | n/a | n/a | n/a | n/a | n/a |
| Operating Income | n/a | -36.73M | -33.32M | -23.53M | -17.71M | -15.60M | -13.79M | -9.99M | -7.45M | -3.23M | -1.15M | -28.12K | -19.62K | -25.64K |
| Interest Income | n/a | 1.18M | 251.40K | 261.82K | 68.07K | 52.66K | n/a | 806.00 | 806.00 | 3.07K | n/a | n/a | n/a | n/a |
| Pretax Income | -38.85M | -31.97M | -33.06M | -23.05M | -17.55M | -15.56M | -12.54M | -10.38M | -8.30M | -2.90M | -1.27M | -31.37K | -22.01K | -26.34K |
| Net Income | -39.43M | -32.54M | -33.64M | -23.13M | -17.67M | -15.58M | -12.54M | -10.38M | -8.30M | -2.90M | -1.27M | -31.37K | -22.01K | -26.34K |
| Selling & General & Admin | 18.25M | 21.91M | 15.66M | 11.29M | 8.90M | 7.00M | 7.23M | 7.05M | 4.52M | 1.43M | 715.02K | 28.12K | 19.62K | 25.64K |
| Research & Development | 11.91M | 14.82M | 17.66M | 12.24M | 8.81M | 8.60M | 6.56M | 2.94M | 2.93M | 1.80M | 437.97K | 492.14K | 705.81 | n/a |
| Other Expenses | 11.84M | -0.00 | 1.45M | 59.92K | 110.21K | 715.98K | 1.27M | 732.15K | 732.15K | 486.27K | n/a | n/a | n/a | n/a |
| Operating Expenses | 42.00M | 36.73M | 33.32M | 23.53M | 17.71M | 15.60M | 13.79M | 9.99M | 7.45M | 3.23M | 1.14M | 28.12K | 19.62K | 25.64K |
| Interest Expense | n/a | n/a | 251.40K | 10.84K | 15.67K | 16.44K | 15.84K | 850.79K | 8.99K | 7.50K | n/a | 3.25K | 2.39K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.31K | n/a |
| Cost & Expenses | n/a | 36.73M | 33.32M | 23.53M | 17.71M | 15.60M | 13.79M | 9.99M | 7.45M | 3.23M | 1.14M | 28.12K | 19.62K | 25.64K |
| Income Tax | 576.00K | 576.00K | 576.00K | 70.76K | 125.88K | 16.44K | 1.28M | 850.79K | 8.99K | 4.43K | -119.14K | -1.18M | -1.02K | n/a |
| Shares Outstanding (Basic) | n/a | 146.13M | 146.08M | 108.60M | 39.17M | 20.16M | 10.73M | 5.48M | 3.62M | 2.12M | n/a | 750.00K | 750.00K | 750.00K |
| Shares Outstanding (Diluted) | n/a | 151.29M | 146.08M | 108.60M | 39.17M | 20.16M | 10.73M | 5.48M | 3.62M | 2.12M | n/a | 750.00K | 750.00K | 750.00K |
| EPS (Basic) | n/a | -0.23 | -0.23 | -0.21 | -0.45 | -0.77 | -1.17 | -1.89 | -2.29 | -1.37 | n/a | -0.04 | -0.03 | -0.04 |
| EPS (Diluted) | n/a | -0.22 | -0.23 | -0.21 | -0.45 | -0.77 | -1.17 | -1.89 | -2.29 | -1.37 | n/a | -0.04 | -0.03 | -0.04 |
| EBITDA | n/a | -36.73M | -32.88M | -22.88M | -17.38M | -15.54M | -13.79M | -9.98M | -7.45M | -3.23M | n/a | n/a | -19.62K | -24.93K |
| Depreciation & Amortization | n/a | 194.32K | 179.68K | 164.87K | 152.36K | 893.00 | 1.75K | 2.63K | 1.34K | 3.07K | 1.15M | 1.18M | 1.02K | 704.00 |